alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

In accordance with the Federal Advisory Committee Act (Pub. L. 92-463, as amended), the National Science Foundation (NSF) announces the following meeting:

*Name and Committee Code:*                     National Artificial Intelligence Research Resource Task Force (84629) (Virtual).                

*Date and Time:*                     December 13, 2021, 11:00 a.m. to 5:00 p.m. EDT.                

*Place:*                     NSF, 2415 Eisenhower Avenue, Alexandria, VA 22314; Virtual meeting.                

                    To attend the virtual meeting, please send your request for the virtual meeting link to the following email:                     *cmessam@nsf.gov.*

*Type of Meeting:*                     Open.                

*Contact Person:*                     Brenda Williams, National Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314; Telephone: 703-292-8900; email:                     *bwilliam@nsf.gov.*

*Purpose of Meeting:*                     The Task Force shall investigate the feasibility and advisability of establishing and sustaining a National Artificial Intelligence Research Resource; and propose a roadmap detailing how such resource should be established and sustained.                

*Agenda:*                     In this meeting, the Task Force will receive readouts from working group discussions held on the topics of priority capabilities for inclusion in a National AI Research Resource, including data resources, user tools and resources, and testing or testbed resources. The Task Force will discuss associated requirements for the resource in terms of security and access controls; and privacy, civil rights, and civil liberties.                

Dated: August 5, 2021.

Crystal Robinson,

Committee Management Officer.

[FR Doc. 2021-16981 Filed 8-9-21; 8:45 am]

BILLING CODE 7555-01-P
#### In the Matter of Carlos Abreu, Petitioner, v Kimberly Cheasman et al., Respondents.

[942 NYS2d 391]

Proceeding pursuant to CPLR article 78 (transferred to the Appellate Division of the Supreme Court in the Fourth Judicial Department by order of the Supreme Court, Seneca County [Dennis F. Bender, A.J.], entered September 22, 2011) to review a determination of respondents. The determination found after a tier III hearing that petitioner had violated various inmate rules.

It is hereby ordered that said proceeding is unanimously dismissed without costs as moot *(see Matter of Free v Coombe,*
      *1408234 AD2d 996 [1996]). Present — Scudder, EJ., Smith, Centra, Fahey and Peradotto, JJ.
# oe..___

6H IN THE SUPREME COURT OF THE STATE OF MONTANA DA 21

- 0591 JOSHUA F. CLARK,

Plaint iff and Appellant,

v. MISSOULA COUNTY SHERIFF TERRY J. MCDERMOTT, th e COUNTY OF MISSOULA, MONTANA, and HUMAN RIGHTS COMMISSION,

Defendants and Appellees. ORDER OF MEDIATOR APPOINTMENT

This appeal being subject to M.R.App.P. 7, and the parti es having failed to j oint ly and timely select a mediator under M.R.App.P., 7(4),(c), IT IS ORDERED THAT **Richard A.**  **Reep,** whose nam e appears next on th e list of attorneys desiring appo int me nt a s med iators for Money J udgments appeals which is maintained pursuant to M.R.App.P., 7(4)(e), is hereby appo int ed to co nduct th e mediat io n process required by M.R.App.P., 7(5), and IT IS FURTH ER ORDERED th at th e time peri ods set fo rth in M.R.App.P., 7(5)(d) shall run from the date of this order of appoint me nt
. A true copy

of this order is being mailed to counsel of record f or the parti es, or to th e parties individually if not represented by co unsel , on the date hereof. DATED thi s December 15, 2021.

Bowen Greenwood , Clerk of the Supreme Court

c: Quent in M. Rhoades, Steven S. Carey , David T. Lighthall, Quinlan L. O'Connor, Ri chard A. Reep 12/15/2021

Case Number: DA 21-0591
**Exhibit 31.1****Sarbanes-Oxley Section 302 Certification**I, Stephen J. Hansbrough, certify that:1. I have reviewed this annual report on Form 10-K of HearUSA, Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forthe registrant and we have: a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluations; and  c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing the equivalent function): a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.Date: March 31, 2006/s/Stephen J. Hansbrough——————————————————Stephen J. Hansbrough
Sherwood J. Reese 

Sherwood.reese@comcast.net 

Drew L. Johnson, P.C. 

sherwoodreese@comcast.net 

1700 Valley River Drive 

Eugene, OR 97401 

(541) 434-6466 

Attorneys for Plaintiff 

UNITED STATES COURT DISTRICT COURT 

ROBERT W. CURRY, 

Plaintiff, 

VS. 

Commissioner of Social Security 

Administration, 

Defendant. 

DISTRICT OF OREGON 

Civil No. 6:14-cv-00881-BR 

ORDER FOR ATTORNEY FEES 

PURSUANT TO EAJA 

After considering the Stipulated Motion of the parties submitted herein, Order hereby 

grants that Commissioner shall pay Plaintiff's attorney the sum of $7450.35 upon verification 

that Plaintiff has no debt to the government which qualifies for offset against the awarded fees, 

pursuant to the reasoning in Astrue v. Ratliff, 560 U.S. 586, 130 S. Ct. 2521, 2527 (2010) (EAJA 

awards fees subject "to a federal administrative offset if the Litigant has outstanding federal 

debts") for full settlement of all claims for fees under EAJA. 

1 -ORDER FOR ATTORNEY FEES PURSUANT TO EAJA 

Case 6:14-cv-00881-BR Document 23 Filed 07/16/15 Page 1 of 2
....., - ---

If Plaintiff has no such federal debt, payment of $7450.35 shall be made to Plaintiff's 

attorneys, Drew L. Johnson, PC, and mailed to their office at 1700 Valley River Drive, Eugene, 

OR 97401. If Plaintiff has such debt, the check for any remaining funds after offset shall be 

made out to Plaintiff and mailed to counsel's office at the address provided above. 

I tL IT IS SO ORDERED this day of July~' 2015 

PRESENTED BY: 

By: Is/ DREW L. JOHNSON 

Drew L. Johnson, OSB #75200 

Of Attorneys for Plaintiff 

U.S. District Judge!Mttgistrate Judge 

2- ORDER FOR ATTORNEY FEES PURSUANT TO EAJA 

Case 6:14-cv-00881-BR Document 23 Filed 07/16/15 Page 2 of 2
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Cereal Crops Research: Madison, WI
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Midwest Area Madison, Wisconsin Cereal Crops Research People & Locations







Laura  Oesterle
                        Cereal Crops Research

                        




                        
                        Biological Laboratory Technical
                        Phone: (608) 262-1154
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT UNITED STATES OF AMERICA, Plaintiff-Appellee, v. No. 95-5959 REGINALD LAMAR DAVIS, Defendant-Appellant. Appeal from the United States District Court for the Western District of North Carolina, at Charlotte. Graham C. Mullen, District Judge. (CR-95-81) Submitted: January 31, 1997 Decided: February 24, 1997 Before MURNAGHAN, WILKINS, and LUTTIG, Circuit Judges.

_________________________________________________________________ Affirmed by unpublished per curiam opinion.

_________________________________________________________________ COUNSELTerry F. Rose, CLOER & ROSE, Hickory, North Carolina, for Appellant. Mark T. Calloway, United States Attorney, Thomas G. Walker, Assistant United States Attorney, Charlotte, North Carolina, for Appellee.

_________________________________________________________________ Unpublished opinions are not binding pr ecedent in this circuit. See Local Rule 36(c).OPINION PER CURIAM: Reginald Lamar Davis appeals from his conviction for aiding and abetting in the commission of a bank robbery in violation of 18 U.S.C. § 2113 (1994), and use of a firearm in a crime of violence in violation of 18 U.S.C. § 924(c) (1994). We affirm. Davis first contends that the district court erred in overruling his objection under Batson v. Kentucky , 476 U.S. 79 (1986), to the Government's use of a peremptory challenge to strike a juror allegedly on account of r ace. Our review reveals that the district court was not clearly erroneous in its finding that the juror was struck not because of race, but because of a delay prior to her affirmance that she wouldfollow the law as instructed by the court, especially when the evidence reveals that three other members of this candidate's race were in fact seated on the jury. Davis next contends that the district court erred in failing toinstruct the jury on the definition of reasonable doubt. This court generally disapproves of judicial efforts to define reasonable doubt absent a specific request from jury itself, and therefore we find no error in the district court's refusal to further define the term. See United States v. Reives , 15 F.3d 42, 46 (4th Cir. 1994) (stating that district court does not err by refusing to instruct jury on meaning of reasonable doubt even when specifically requested by the jury).Finally, Davis contends that there was insufficient evidence to support his conviction for aiding and abetting in the robbery. We find,when viewing the evidence in its totality and in the light most favorable to the Government, that there is ample evidence from which a reasonable trier of fact could find Davis guilty beyond a reasonable doubt. Glasser v. United States , 315 U.S. 60, 80 (1942). Accordingly, we affirm Davis' conviction. We dispense with oralargument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.
AFFIRMED
2
**Exhibit 31.1**
****CERTIFICATION****
I, Paul L. Ruflin, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Eclipsys Corporation;
2. Based on my knowledge, this report does not contain any untrue statement ofa material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements weremade, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, includingits consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is beingprepared;
b) [Paragraph omitted in accordance with SEC transition instructionscontained in SEC Release 34-47986]
c) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end ofthe period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in thecase of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control overfinancial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal controlover financial reporting.       /s/ Paul L. Ruflin     Dated: November 6, 2003  Paul L. Ruflin
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Microbial and Chemical Food Safety: Wyndmoor, PA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    About ERRC
                        Greetings from the Director
                                    Directions/Lodging
                                    History and Accomplishments
                    Our Work
                        Biomass Pyrolysis Research
                                    IPMP 2013
                                    IPMP Dynamic Prediction
                                    IPMP Global Fit
                                    Pathogen Modeling Program (PMP)
                                    Predictive Microbiology Information Portal (PMIP)
                                    PoultryFARMSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Wyndmoor, Pennsylvania Eastern Regional Research Center Microbial and Chemical Food Safety People & Locations







Stacy  Raleigh
                        Microbial and Chemical Food Safety

                        




                        
                        Biological Science Laboratory Technician (Microbiology)
                        Phone: (215) 233-6437
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
II

105TH CONGRESS

1ST SESSION S. 1481

To amend the Social Security Act to eliminate the time limitation on benefits

for immunosuppressive drugs under the medicare program, to provide

for continued entitlement for such drugs for certain individuals after

medicare benefits end, and to extend certain medicare secondary payer

requirements.

IN THE SENATE OF THE UNITED STATES

NOVEMBER 8, 1997

Mr. DEWINE introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To amend the Social Security Act to eliminate the time

limitation on benefits for immunosuppressive drugs under

the medicare program, to provide for continued entitlement for such drugs for certain individuals after medicare benefits end, and to extend certain medicare secondary payer requirements.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Immunosuppressive

5 Drugs Coverage Act of 1997’’.
2

•S 1481 IS

1 SEC. 2. ELIMINATION OF TIME LIMITATION ON MEDICARE

2 BENEFITS FOR IMMUNOSUPPRESSIVE

3 DRUGS.

4 (a) IN GENERAL.—Section 1861(s)(2)(J) of the So5 cial Security Act (42 U.S.C. 1395x(s)(2)(J)) is amended

6 by striking ‘‘, but only’’ and all that follows up to the semi7 colon at the end.

8 (b) EFFECTIVE DATE.—The amendment made by

9 subsection (a) shall apply to drugs furnished on or after

10 the date of the enactment of this Act.

11 SEC. 3. CONTINUED ENTITLEMENT FOR IMMUNO12 SUPPRESSIVE DRUGS FOR CERTAIN INDIVID13 UALS AFTER MEDICARE BENEFITS END.

14 (a) IN GENERAL.—Section 226A(b)(2) of the Social

15 Security Act (42 U.S.C. 426–1(b)(2)) is amended by in16 serting ‘‘(except for the provision of immunosuppressive

17 drugs pursuant to section 1861(s)(2)(J))’’ after ‘‘shall

18 end’’.

19 (b) EFFECTIVE DATE.—The amendment made by

20 subsection (a) shall apply to drugs furnished on or after

21 the date of the enactment of this Act.

22 SEC. 4. EXTENSION OF CERTAIN SECONDARY PAYER RE23 QUIREMENTS.

24 Section 1862(b)(1)(C) of the Social Security Act (42

25 U.S.C. 1395y(b)(1)(C)) is amended by adding at the end

26 the following: ‘‘With regard to immunosuppressive drugs
3

•S 1481 IS

1 furnished on or after the date of enactment of the Im2 munosuppressive Drugs Coverage Act of 1997, this sub3 paragraph shall be applied without regard to any time lim4 itation.’’.

Æ